A Phase II study of Temsirolimus (CCI-779) in patients with metastatic and/or recurrent endometrial cancer - NCICCTG IND 160 Conferences uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Oza, AM
  • Elit, Laurie
  • Biagi, J
  • Panasci, L
  • Tonkin, K
  • Tsao, M
  • Dore, N
  • Dancey, J
  • Eisenhauer, E
  • Seymour, L

publication date

  • October 1, 2005